JMJames McCaslin

James McCaslin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James McCaslin has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rotational Percutaneous Mechanical Thrombectomy for Acute and Subacute Limb Ischaemia: A Systematic Review and Proportional Meta-Analysis

    by Benedict Stanberry, Koen Deloose, Yann Gouëffic, Gilles Goyault, Giacomo Isernia, Ralph Jackson, Nils Kucher, Michael Lichtenberg, James McCaslin, Bruno Migliara, et al.

    Objective: Rotational percutaneous mechanical thrombectomy with adjunctive angioplasty, stenting or limited thrombolysis (rPMT+) has become commonplace in the treatment of acute and subacute limb ischaemia (SLI). This systematic review and proportional meta-analysis synthesises the available evidence on its safety and efficacy. Data Sources: MEDLINE, Embase and the Cochrane Library. Review Methods: We searched for studies (≥10 patients) published since January 1, 2012 (PROSPERO protocol CRD420251015846). Risk of bias was assessed using RoBANS 2. Proportional meta-analysis maximised representative sample sizes by incorporating both single-arm and comparative studies. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) evidence profiles were developed for each outcome of interest. Results: Twenty-four studies – 7 comparative and 17 single arm – containing 2954 procedures (2697 rPMT+, 257 controls) met eligibility criteria. There were no randomised controlled trials. The pooled technical success (TS) rate for rPMT+ was 98% (95% confidence interval [CI]: 97%–100%, p < .001). Amputation-free survival (AFS) was 96% (95% CI: 93%–98%, p < .001). Twelve-month primary patency (PP) was 68% (95% CI: 55%–79%, p < .001). The pooled rate of freedom from clinically-driven target lesion revascularisation was 85% (95% CI: 80%–90%, p < .001). No significant differences existed between acute, subacute and mixed subgroups. Procedure-related mortality was 0.5% (11 deaths in 2086 procedures from 17 studies) with most deaths occurring after adjunctive catheter-directed thrombolysis. Major adverse events occurred in 4% of procedures (95% CI: 1%–8%, p < .001) and distal embolisation in 8% (95% CI: 5%–11%, p < .001). rPMT+ reduced length of stay by 1.7 days versus alternatives (95% CI: 3.3%–0.1 days, p < .05). All outcomes demonstrated heterogeneity; GRADE assessment rated evidence certainty as low to very low. Conclusion: The evidence available from 24 real-world observational studies of 2954 procedures supports the use of rPMT+ in acute limb ischaemia and SLI – delivering an overall pooled TS rate of 98% and AFS rate of 96% with no significant differences between acute, subacute and mixed subgroups. rPMT+ is associated with shorter hospital stays than either surgery or thrombolysis. Clinical Impact: This systematic review and proportional meta-analysis synthesises 24 single-arm and comparative non-randomised studies encompassing nearly 3000 procedures to provide a comprehensive assessment of the safety and efficacy of rotational percutaneous mechanical thrombectomy in patients with acute and subacute lower limb ischaemia. It demonstrates that, when used for initial revascularisation prior to adjunctive angioplasty, stenting or limited thrombolysis, this endovascular approach delivers clinically valuable rates of technical success and amputation-free survival with notably high rates of freedom from clinically-driven target lesion revascularisation, acceptable primary patency, low procedural risk and significantly shorter hospital stays.

  • Open Access

    Rotational Percutaneous Mechanical Thrombectomy for Acute and Subacute Limb Ischaemia: a Systematic Review and Proportional Meta-analysis

    by Benedict Stanberry, Koen Deloose, Yann Gouëffic, Gilles Goyault, Giacomo Isernia, Ralph Jackson, Nils Kucher, Michael Lichtenberg, James McCaslin, Bruno Migliara, et al.

    Objective: Rotational percutaneous mechanical thrombectomy with adjunctive angioplasty, stenting or limited thrombolysis (rPMT+) has become commonplace in the treatment of acute and subacute limb ischaemia. This systematic review and proportional meta-analysis synthesises the available evidence on its safety and efficacy. Data Sources: MEDLINE, Embase and the Cochrane Library. ≥ Review Methods: We searched for studies (≥10 patients) published since 1 January 2012 (PROSPERO protocol CRD420251015846). Risk of bias was assessed using RoBANS 2. Proportional meta-analysis maximised representative sample sizes by incorporating both single-arm and comparative studies. GRADE evidence profiles were developed for each outcome of interest. Results: Twenty-four studies – seven comparative and 17 single arm – containing 2,954 procedures (2,697 rPMT+, 257 controls) met eligibility criteria. There were no randomised controlled trials. The pooled technical success (TS) rate for rPMT+ was 98% (95% CI: 97-100%, p p p p p p p <0.05). All outcomes demonstrated heterogeneity. GRADE assessment rated evidence certainty as low to very low. Conclusion: rPMT+ delivers consistently high TS and AFS rates, promising 12-month fCDTLR, acceptable PP, low procedural risk and shorter hospital stays than comparators. The consistency of favourable outcomes supports its use as a safe and effective treatment in appropriately selected ALI and SLI patients. WHAT THIS PAPER ADDS: This systematic review and proportional meta-analysis synthesises 24 single-arm and comparative non randomised studies encompassing nearly 3,000 procedures to provide a comprehensive assessment of the safety and efficacy of rotational percutaneous mechanical thrombectomy in patients with acute and subacute lower limb ischaemia. It demonstrates that, when used for initial revascularisation prior to adjunctive angioplasty, stenting or limited thrombolysis, this endovascular approach delivers consistently high rates of technical success and amputation-free survival with notably high rates of freedom from clinically-driven target lesion revascularisation, acceptable primary patency, low procedural risk and significantly shorter hospital stays.

  • Social Deprivation and the Association With Survival Following Fenestrated Endovascular Aneurysm Repair

    by Ehsanul Choudhury, James Rammell, Nikesh Dattani, Robin Williams, James McCaslin, James Prentis, Sandip Nandhra


  • Open Access

    Using an Endovascular Strategy in the Open Setting: The Challenges of Hybrid Repair Using Frozen Elephant Trunk in an Extensively Dilated Aorta Associated with Coarctation

    by Bertram Harrington, Iain McPherson, Christopher Bayliss, Sion Barnard, James McCaslin, Robin Williams, Karen Booth

    With both stenosis and aneurysm, repairing a severely tortuous and coarcted aorta can present certain difficulties. The advent of hybrid arch frozen elephant trunk techniques, as well as other endovascular solutions, has produced safer surgical repair methods for such cases. We present the reconstruction and repair of a Type-1 thoracoabdominal aortic aneurysm using a staged approach in less-than-optimal anatomy. Interventions included hybrid frozen elephant trunk, balloon dilation, and thoracic endovascular repair.